Skip to content

Wet Lab Resources and News for your Biotech Incubator, Research Park, or Association

 

Date: March 2, 2010
Time: 12:00PM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
 
The achievement of a cleared Investigational New Drug application (IND) is a critical milestone for most small to mid-sized companies.  Senior Management teams face many challenges when working on these applications.  These are not easy applications to create, and there are many potential pitfalls. During this presentation the pitfalls that CEOs and senior management teams need to be aware of will be identified.  A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel. Webinar link-up is available for those who are not able to participate on-site. Please indicate if you would like to join by webinar when signing up. The details for the webinar will be sent to participants before the event. | Registration fee: from $0 to $40 | 12:00-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Speakers: Debra Gosling, Account Executive, Regulatory & Clinical Services, Liquent Inc. | Tom Delisi, Senior Consultant, Regulatory Services, Liquent Inc. | Kathryn Plank, Senior Regulatory Consultant, Liquent Inc. | Jim Hilferty, Operations Manager, Regulatory & Clinical Services, Liquent Inc.

 

Building, Compensating & Motivating
a Leadership Team
qed@qb3 - UCSF
Thursday, February 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212

 One of the most critical factors for a company's success is building an excellent team, but finding, recruiting, compensating, and ultimately motivating the best people is extremely challenging.  Chris McKinley and Michael Ballenger bring decades of HR and executive recruitment experience to this subject and will share their insights and advice in this seminar.

Speakers

 

Christine McKinley has 30 years experience working in entrepreneurial, high growth biotech and medical companies. Prior to founding Round One Resources, she was Sr.VP of Human Resources at Cell Genesys, responsible for strategic and operational HR initiatives, involving extensive staffing of a manufacturing facility, expansion of process development, manufacturing and clinical operations, merger, acquisition and restructuring activities. She began as one of the earlier employees of Genentech. 

Michael Ballenger specializes in Board of Director, CEO searches as well as officer-level assignments in research, product development and all business functions. He has 23 years of experience in executive search in all segments of the life science/healthcare product industry and has focused his last 10 years on work with start-up and development stage companies. He was previously the Managing Partner of Highland Partner's San Francisco office where he built the company's first Life Science/Healthcare Products Practice and was also Sr. Director of Human Resources for Genentech.

Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197756

 

 

FOR IMMEDIATE RELEASE:                                                                 Date: 1/27/10
Contact:
Angus G. McQuilken
Vice President for Communications
Cell: 617-921-7749
amcquilken@masslifesciences.com 
 
$3 million available to match federal grant funding for early-stage life sciences companies
 
Waltham, Massachusetts –The Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the state’s ten year, $1 billion Life Sciences Initiative, today launched a new Small Business Matching Grant (SBMG) program that will match federal small business grant funding for early-stage life sciences companies in Massachusetts. $3 million will be made available for the program for Fiscal Year 2010. The Center will begin accepting on-line applications for the new program on Monday, February 1, 2010. Applications will be submitted via the Center’s web site at www.masslifesciences.com.

 

Grantwriting 101
including SBIR and STTRs
 
qed@qb3 - UCB
Friday, February 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621

SBIR/STTR grants can provide the critical funding necessary to launch your company.  But success requires mastering the tricks of the SBIR/STTR program, some of which have frustrated excellent groups.  From where to register to uploading your proposal, we'll cover the ins and outs of preparing grants for the NIH.  This seminar is aimed at new and experienced grantwriters, from academia and industry. Even veteran grantwriters will benefit from a review of the new formats required as of January 2010. 

Speakers

 

Shauna Farr-Jones has a 10-year record of writing successful government grant and contract proposals on diverse life science topics, providing strategic input on both research and business plans. She has helped companies secure over $125 million in grant and contract funding from government and philanthropic agencies. Previously, she was at BioCentury Publications, where she analyzed the biotechnology industry. She was a postdoc in PharmChem at UCSF after a Ph.D. in Biochem from Tufts.  

Amy F. Boggs is an independent consultant witmorthan 8 years experience in grant-writing. She also handles the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning, and competitive landscaping. Prior, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team. Dr. Boggs is an inventor on three issued patents and has worked on IND-enabling projects. She completed a Ph.D. in PharmChem at UCSF under Dr. Agard.

Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197134  

 


Now, more than ever, start-ups can use all the help they can get. The
San Jose BioCenter will provide your biotech or cleantech company with support for fundraising, business development, legal, lab support, HR and payroll activities, as well as, provide you with access to our $15 million dollar state-of-the-art laboratory facilities and shared equipment.

“In just 5 years San Jose BioCenter companies have raised over $1 Billion in deals and financing.” -Melinda Richter, Executive Director, San Jose BioCenter

Our mission is to provide life science and cleantech companies with the infrastructure, resources, networks and expertise they need to develop and commercialize their technology. The
San Jose BioCenter was awarded the National Business Incubator Association (NBIA) International Incubator of the year award for 2009 because of our exceptional resources, programs and client success rate. After 1.5 years at the San Jose BioCenter, Tacere Pharmaceuticals inked a $145m development deal with Pfizer for its preclinical hepatitis C drug:

 

 

 

For Immediate Release
February 3, 2010

Media inquiries
Dennis J. Barger ● Principal, Vail Academy and High School ● (520) 879-1904 ● bargerd@vail.k12.az.us
Jessa B. Turner ● Media & Public Relations Coordinator ● (520) 382-2485 ● jbturner@uatechpark.org
 
(Tucson, Arizona) Today, the Vail School District broke ground on the Vail Academy & High School, the district’s first K-12 school and the nation’s first K-12 school located at a university research park.
 
Vail High School began offering classes at the Tech Park in July 1997.  Vail Academy (K-8) will join the already established Vail High School at a new site in the Tech Park.  The 34,000 square foot facility is scheduled to open in July 2010. 
 
The K-12 school will house 225 K-8 students and 225 high school students.  Each grade level will accommodate approximately 25 students.  The small class size provides an interactive environment where students receive personal attention.  The K-12 model allows the curriculum to build on the previous grades' teaching, which provides a consistent educational foundation and the development of vast knowledge around important concepts.

 

 

Date: February 3, 2010
Time: 2:30PM-3:30PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: free
The Open House Tour is an opportunity for anyone interested in the BioCenter to tour the facility and the Core Labs, to meet the management, and learn more about the BioCenter history and its clients. The Tour starts at 2:30 and lasts around an hour depending on attendance and how curious you are! | Registration fee: free | 2:30-3:30 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138

 

 

 

Showcase your business; get exposure to local investors and business leaders and compete for a chance to win $25,000 in cash!

Open to all for-profit companies headquartered in the nine-county, Greater Rochester New York Region, this annual contest encourages entrepreneurship and recognizes new, high-growth ventures. Learn about the contest. Register for the contest starting February 1, 2010.
 
The finalists will present before a live audience and panel of judges. The winners will be announced at the 2nd Annual Celebration of Entrepreneurship Luncheon Friday, April 30th, 2010. Register for the luncheon.
 
Prizes
 
  • Contest finalists will receive significant community exposure and marketing services from Dixon Schwabl
  • 1st, 2nd, and 3rd place winners will also receive cash prizes and free office space at HTR’s Lennox Tech Enterprise Center or Rochester BioVenture Center
Sponsorships
 
Support entrepreneurship in our community. Become a sponsor of the contest! Contact Jackie Spiro for more information.
 
Contest Information and Guidelines
 
All contest information is available at www.htr.org/bpcontest
Contact BusinessPlan@htr.org  or 585-214-2400 with questions

 

Bread Board's NextFab Studio opened January 22, allowing students, adults, researchers and companies to fabricate and prototype novel designs in 3D.  NextFab and Bread Board's Esther Klein Gallery which had an opening for the Brower Jet Propulsion Laboratory in conjunction with the open house, brought the public into the Science Center to share in the excitement and possibility that is always present.  

The 3,600 square foot production space much like the gallery across the street meets a number of needs.  It provides access to the materials that will generate both conceptual and physical innovation, so that the life cycle of information and commerce may perpetuate.  

 
RoseAnn B. Rosenthal spoke to the U.S. House Committee on Science and Technology with advice for
the Department of Commerce’s new Office of Innovation and Entrepreneurship

WASHINGTON, D.C. (www.sep.benfranklin.org) – RoseAnn B. Rosenthal, President & CEO of Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP), yesterday testified before the U.S. House Committee on Science and Technology’s subcommittee on Technology and Innovation. 
 
Rosenthal was asked to testify because of her track record in Pennsylvania’s technology community, expertise in the industry, and role within Ben Franklin.  Since 2001 alone, Ben Franklin has committed more than $50 million to over 500 early stage companies, which have created or retained over 7000 high-tech jobs.  During that time Ben Franklin’s portfolio companies have raised more than a billion dollars in follow-on investment.

Luminogenics is a resource with interests in systems of technology commercialization in the life sciences. Included here is a directory of hundreds of biotech incubators, research parks, and associations.



Powered by Drupal, an open source content management system
AdaptiveThemes